Directly observed therapy (DOT): from tuberculosis to HIV (Q45000369)

8 December 2017

1 reference

title

Directly observed therapy (DOT): from tuberculosis to HIV (English)

1 reference

8 December 2017

Machouf N

1

1 reference

8 December 2017

Lalonde RG

series ordinal

2

1 reference

8 December 2017

publication date

1 February 2006

1 reference

Revue d'epidemiologie et de sante publique

8 December 2017

published in

1 reference

8 December 2017

volume

54

1 reference

8 December 2017

issue

1

1 reference

8 December 2017

page(s)

73-89

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Interventions to improve adherence to antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Chronic disease self-management and adherence to HIV medications.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Addressing the challenges of adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Outcomes of a health education intervention in a sample of patients infected by HIV, most of them injection drug users: possibilities and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Modified directly observed therapy for treatment of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Should directly observed therapy be considered for treatment of HIV?

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Medication adherence strategies for drug abusers with HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Directly observed therapy and treatment adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Directly observed therapy to treat HIV infection in prisoners

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Directly observed therapy in HIV therapy: A realistic perspective?

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

A simple, once-daily dosing regimen for treating HIV-1 infection in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Directly observed therapy for the management of HIV-infected patients in a methadone program

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Has directly observed treatment improved outcomes for patients with tuberculosis in southern Thailand?

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Pilot study of directly observed therapy in highly nonadherent HIV-infected patients in an urban community-based institution

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Long-term Clinical Follow-up, without Antiretroviral Therapy, of Patients with Chronic HIV-1 Infection with Good Virological Response to Structured Treatment Interruption

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Factors affecting patient adherence to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Medication noncompliance and substance abuse among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Randomized controlled trial to assess the effectiveness of a primary health care liaison worker in promoting shared care for opiate users

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

What makes DOT work? Directly observed therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Doubts about DOT: antiretroviral therapy for resource-poor countries

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Linking injection drug users to medical services: role of street outreach referrals

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Barriers to use of free antiretroviral therapy in injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Nonadherence among HIV-infected injecting drug users: the impact of social instability

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?

1 reference

https://api.crossref.org/works/10.1016%2FS0398-7620%2806%2976696-2

7 January 2021

10.1016/S0398-7620(06)76696-2

Identifiers

DOI

1 reference

8 December 2017

1 reference